AR and breast carcinoma: In general, the link with androgens is stronger at the benign end of the spectrum, but some malignant tumors in the apocrine group also show increased expression of androgen receptor target genes, and a breast cancer cell line (MDA-MB-453) with a molecular apocrine gene expression profile was recently shown to be androgen-dependent for growth [36].